مقالات علمی
https://ctrmrc.tums.ac.ir/مقالات علمی/صفحه:1
لیست مقالات علمیلیست اخبار صفحه :1 Metabolic fingerprinting of human plasma in dementia A pilot study of metabolome decomposition Metabolic fingerprinting of human plasma in dementia A pilot study of metabolome decomposition 1404/07/30 - 14:44 Background: As the number of people with dementia grows, it becomes even more important to improve how it is diagnosed and treated. Metabolomics, the study of small molecule metabolites in biological systems, helps us learn a lot about dementia by revealin
مقالات انگلیسی
https://ctrmrc.tums.ac.ir/article/صفحه:4
لیست اخبار صفحه :4 GMP-Compliant Mesenchymal Stem Cell-Derived Exosomes for Cell-Free Therapy in Cancer GMP-Compliant Mesenchymal Stem Cell-Derived Exosomes for Cell-Free Therapy in Cancer 1402/11/14 - 12:33 Cancer is categorized as one of the life-threatening disease in the world, which has recently been associated with a significant increase in the incidence and prevalence rate. Hence, the discovery of effective approaches for prevention, early diagnosis, and effective treatment for cancer has
Obesity in COVID19 era implications for mechanisms comorbidities and prognosis a review and meta analysis
https://ctrmrc.tums.ac.ir/مقالات-علمی/Obesity-in-COVID19-era-implications-for-mechanisms-comorbidities-and-prognosis-a-review-and-meta-analysis
Obesity in COVID19 era implications for mechanisms comorbidities and prognosis a review and meta analysis Obesity in COVID19 era implications for mechanisms comorbidities and prognosis a review and meta analysis Obesity in COVID19 era implications for mechanisms comorbidities and prognosis a review and meta analysis Background: Recent studies have shown that obesity is associated with the severity of coronavirus disease (COVID-19). We reviewed clinical studies to clarify the obesity relationship
Mesenchymal stem stromal cells as a valuable source for the treatment of immune mediated disorders
https://ctrmrc.tums.ac.ir/news/Mesenchymal-stem-stromal-cells-as-a-valuable-source-for-the-treatment-of-immune-mediated-disorders/304040
Mesenchymal stem stromal cells as a valuable source for the treatment of immune mediated disorders Mesenchymal stem stromal cells as a valuable source for the treatment of immune mediated disorders Mesenchymal stem stromal cells as a valuable source for the treatment of immune mediated disorders Over recent years, mesenchymal stem/stromal cells (MSCs) and their potential biomedical applications have received much attention from the global scientific community in an increasing manner. Firstly, MS
Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence
https://ctrmrc.tums.ac.ir/مقالات-علمی/Changes-in-clinic-visits-and-diabetes-and-metabolic-control-in-patients-with-type-2-diabetes-during-COVID–19-pandemic:-A-real-world-evidence
Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real wo Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence Purpose: The study aim was to evaluate the effects of public lockdown during the covid-19
Critical roles of cytokine storm and bacterial infection in patients with COVID-19
https://ctrmrc.tums.ac.ir/مقالات علمی/Critical-roles-of-cytokine-storm-and-bacterial-infection-in-patients-with-COVID–19
Critical roles of cytokine storm and bacterial infection in patients with COVID-19 Critical roles of cytokine storm and bacterial infection in patients with COVID-19 Critical roles of cytokine storm and bacterial infection in patients with COVID-19 This virus can affect all systems of the body and its symptoms vary from a simple upper respiratory infection to fatal complications including end-organ damage. Secondary bacterial co-infection is another problem in COVID-19 which affects the prognosi
Long COVID and Stem Cell Therapy
https://ctrmrc.tums.ac.ir/مطالب-آموزشی/Long-COVID-and-Stem-Cell-Therapy
Long COVID and Stem Cell Therapy Long COVID and Stem Cell Therapy Long COVID and Stem Cell Therapy long COVID has more than 200 potential symptoms and can affect almost every organ in the body. With more than 65 million people now estimated to with this often-disabling condition worldwide, and numbers growing daily, there is a desperate need to understand the underlying biology driving it. To find out more about this long COVID infection – or post-acute sequelae SARS-CoV-2 (PASC), as it is incre
A systematic study of nano-based fibrous systems: Diagnostic and
https://ctrmrc.tums.ac.ir/article/A-systematic-study-of-nano–based-fibrous-systems:-Diagnostic-and-therapeutic-approaches-for-dementia-control
A systematic study of nano-based fibrous systems: Diagnostic and A systematic study of nano-based fibrous systems: Diagnostic and therapeutic approaches for dementia control A systematic study of nano-based fibrous systems: Diagnostic and therapeutic approaches for dementia control Over the last few years, protein-based nanofibrous biomaterials have been used for better controlling dementia. PubMed, Scopus, and ISI Web of Science were consulted for available articles on nano-based fibrous system
Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19
https://ctrmrc.tums.ac.ir/article/Safety-and-feasibility-study-of-ex-vivo-expanded-allogeneic–NK-cells-infusion-in-patients-with-acute-pneumonia-caused-by-COVID–19
Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19 Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19 Infusion of allogeneic NK cells might be a complementary treatment to boost immune system function in COVID-19 patients. In this project, we focused on COVID-19 patients with low inspiratory capacity (LIC). This project aims to evaluate the
Human placenta-derived mesenchymal stem cells transplantation in
https://ctrmrc.tums.ac.ir/مقالات-علمی/Human-placenta–derived-mesenchymal-stem-cells-transplantation-in-patients-with-acute-respiratory-distress-syndrome-(ARDS)-caused-by-COVID–19-(phase-I-clinical-trial):-safety-profile-assessment
Human placenta-derived mesenchymal stem cells transplantation in Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment Acute respiratory distress syndrome (ARDS) is one of the most important causes of death in COVID-19 patients. Mes
